These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25609598)

  • 61. GRK3 deficiency elicits brain immune activation and psychosis.
    Sellgren CM; Imbeault S; Larsson MK; Oliveros A; Nilsson IAK; Codeluppi S; Orhan F; Bhat M; Tufvesson-Alm M; Gracias J; Kegel ME; Zheng Y; Faka A; Svedberg M; Powell SB; Caldwell S; Kamenski ME; Vawter MP; Schulmann A; Goiny M; Svensson CI; Hökfelt T; Schalling M; Schwieler L; Cervenka S; Choi DS; Landén M; Engberg G; Erhardt S
    Mol Psychiatry; 2021 Nov; 26(11):6820-6832. PubMed ID: 33976392
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Metabolic, hormonal and stress-related molecular changes in post-mortem pituitary glands from schizophrenia subjects.
    Krishnamurthy D; Harris LW; Levin Y; Koutroukides TA; Rahmoune H; Pietsch S; Vanattou-Saifoudine N; Leweke FM; Guest PC; Bahn S
    World J Biol Psychiatry; 2013 Sep; 14(7):478-89. PubMed ID: 22248022
    [TBL] [Abstract][Full Text] [Related]  

  • 63.
    Teraishi T; Kajiwara M; Hori H; Sasayama D; Hidese S; Matsuo J; Ishida I; Kajiwara Y; Ozeki Y; Ota M; Hattori K; Higuchi T; Kunugi H
    J Psychiatr Res; 2018 Apr; 99():142-150. PubMed ID: 29454221
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Specificity of polygenic signatures across symptom dimensions in bipolar disorder: an analysis of UK Bipolar Disorder Research Network data.
    Allardyce J; Cardno AG; Gordon-Smith K; Jones L; Di Florio A; Walters JTR; Holmans PA; Craddock NJ; Jones I; Owen MJ; Escott-Price V; O'Donovan MC
    Lancet Psychiatry; 2023 Aug; 10(8):623-631. PubMed ID: 37437579
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Lower [3H]LY341495 binding to mGlu2/3 receptors in the anterior cingulate of subjects with major depressive disorder but not bipolar disorder or schizophrenia.
    McOmish CE; Pavey G; Gibbons A; Hopper S; Udawela M; Scarr E; Dean B
    J Affect Disord; 2016 Jan; 190():241-248. PubMed ID: 26521087
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The Relationship between the Level of Anterior Cingulate Cortex Metabolites, Brain-Periphery Redox Imbalance, and the Clinical State of Patients with Schizophrenia and Personality Disorders.
    Bryll A; Krzyściak W; Karcz P; Śmierciak N; Kozicz T; Skrzypek J; Szwajca M; Pilecki M; Popiela TJ
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32899276
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Exploring the borders of the schizoaffective spectrum: a categorical and dimensional approach.
    Peralta V; Cuesta MJ
    J Affect Disord; 2008 May; 108(1-2):71-86. PubMed ID: 18029027
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Membrane lipids in schizophrenia and early phases of psychosis: Potential biomarkers and therapeutic targets?].
    Frajerman A; Kebir O; Chaumette B; Tessier C; Lamazière A; Nuss P; Krebs MO
    Encephale; 2020 Jun; 46(3):209-216. PubMed ID: 32151446
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Temporal, Diagnostic, and Tissue-Specific Regulation of NRG3 Isoform Expression in Human Brain Development and Affective Disorders.
    Paterson C; Wang Y; Hyde TM; Weinberger DR; Kleinman JE; Law AJ
    Am J Psychiatry; 2017 Mar; 174(3):256-265. PubMed ID: 27771971
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Sensory integration deficits support a dimensional view of psychosis and are not limited to schizophrenia.
    Carter O; Bennett D; Nash T; Arnold S; Brown L; Cai RY; Allan Z; Dluzniak A; McAnally K; Burr D; Sundram S
    Transl Psychiatry; 2017 May; 7(5):e1118. PubMed ID: 28485725
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A comparison of neuropsychological dysfunction in first-episode psychosis patients with unipolar depression, bipolar disorder, and schizophrenia.
    Hill SK; Reilly JL; Harris MS; Rosen C; Marvin RW; Deleon O; Sweeney JA
    Schizophr Res; 2009 Sep; 113(2-3):167-75. PubMed ID: 19450952
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Abnormalities of the NMDA Receptor and Associated Intracellular Molecules in the Thalamus in Schizophrenia and Bipolar Disorder.
    Clinton SM; Meador-Woodruff JH
    Neuropsychopharmacology; 2004 Jul; 29(7):1353-62. PubMed ID: 15054476
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Revisiting DARPP-32 in postmortem human brain: changes in schizophrenia and bipolar disorder and genetic associations with t-DARPP-32 expression.
    Kunii Y; Hyde TM; Ye T; Li C; Kolachana B; Dickinson D; Weinberger DR; Kleinman JE; Lipska BK
    Mol Psychiatry; 2014 Feb; 19(2):192-9. PubMed ID: 23295814
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Oxytocin receptor mRNA expression in dorsolateral prefrontal cortex in major psychiatric disorders: A human post-mortem study.
    Lee MR; Sheskier MB; Farokhnia M; Feng N; Marenco S; Lipska BK; Leggio L
    Psychoneuroendocrinology; 2018 Oct; 96():143-147. PubMed ID: 29940428
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Contrasting changes in DRD1 and DRD2 splice variant expression in schizophrenia and affective disorders, and associations with SNPs in postmortem brain.
    Kaalund SS; Newburn EN; Ye T; Tao R; Li C; Deep-Soboslay A; Herman MM; Hyde TM; Weinberger DR; Lipska BK; Kleinman JE
    Mol Psychiatry; 2014 Dec; 19(12):1258-66. PubMed ID: 24322206
    [TBL] [Abstract][Full Text] [Related]  

  • 76. An atlas of genetic correlations between psychiatric disorders and human blood plasma proteome.
    Cheng S; Guan F; Ma M; Zhang L; Cheng B; Qi X; Liang C; Li P; Kafle OP; Wen Y; Zhang F
    Eur Psychiatry; 2020 Feb; 63(1):e17. PubMed ID: 32093803
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Emotion recognition deficits in schizophrenia-spectrum disorders and psychotic bipolar disorder: Findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study.
    Ruocco AC; Reilly JL; Rubin LH; Daros AR; Gershon ES; Tamminga CA; Pearlson GD; Hill SK; Keshavan MS; Gur RC; Sweeney JA
    Schizophr Res; 2014 Sep; 158(1-3):105-12. PubMed ID: 25052782
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Increased systemic cortisol metabolism in patients with schizophrenia and bipolar disorder: a mechanism for increased stress vulnerability?
    Steen NE; Methlie P; Lorentzen S; Hope S; Barrett EA; Larsson S; Mork E; Almås B; Løvås K; Agartz I; Melle I; Berg JP; Andreassen OA
    J Clin Psychiatry; 2011 Nov; 72(11):1515-21. PubMed ID: 21367348
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression.
    Fatemi SH; Earle JA; McMenomy T
    Mol Psychiatry; 2000 Nov; 5(6):654-63, 571. PubMed ID: 11126396
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Role of Astrocytes in Major Neuropsychiatric Disorders.
    Zhang X; Alnafisah RS; Hamoud AA; Shukla R; Wen Z; McCullumsmith RE; O'Donovan SM
    Neurochem Res; 2021 Oct; 46(10):2715-2730. PubMed ID: 33411227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.